HFNO Improves Blood Oxygen Saturation During Asphyxia During Pulmonary Surgery With Double-lumen Endotracheal Intubation
Lung Neoplasms, Pneumothorax
About this trial
This is an interventional treatment trial for Lung Neoplasms
Eligibility Criteria
Inclusion Criteria: Age 18-60; Patients planning to undergo video-assisted thoracoscopic (VATS) lung surgery requiring DLT intubation; Patients who agreed to participate in this study. Exclusion Criteria: American Society of Anesthesiologists (ASA) classification > IV; Patients with severe nasal obstruction; expected difficult intubation or difficulty with mask ventilation; Morbid obesity [Body Mass Index (BMI)>35kg/m2)]; Airway anatomical abnormalities; Abnormal coagulation function; Emergency surgery; Patients at high risk of reflux aspiration, including ileus, full stomach, esophageal reflux disease; Pregnant or breastfeeding women.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
HFNO group
Control group
Direct guidance and positioning of DLT intubation with FOB visualization, using HFNO during intubation asphyxia.
The DLT cannula was directly guided and positioned under FOB visualization, and no oxygen therapy equipment was used during intubation.